It has been found that SLAMF3 is strongly and constitutively expressed in MM cells independent of the malignancy stage and that SLAMF3 knockdown/knockout reduces proliferative capacity and promotes drug-induced apoptosis in MM cells (101). This evidence concerns the gene LY9 and Miyoshi myopathy.